DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. - Wikidata - thesis-toulmin - TriplyDB

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

http://www.wikidata.org/entity/Q27851466

about

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience Recent progress in pancreatic cancer Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer FAK and paxillin, two potential targets in pancreatic cancer Neoadjuvant radiotherapeutic strategies in pancreatic cancer Adjuvant therapy for pancreas cancer in an era of value based cancer care Management of borderline resectable pancreatic cancer Advances of stereotactic body radiotherapy in pancreatic cancer Perspectives in the treatment of pancreatic adenocarcinoma Neoadjuvant therapy for localized pancreatic cancer: guiding principles Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction Advances in systemic therapy for advanced pancreatobiliary malignancies Molecular landscape of pancreatic cancer: implications for current clinical trials Unexpected gynecologic findings during abdominal surgery Evolution and dynamics of pancreatic cancer progression Selection criteria in resectable pancreatic cancer: a biological and morphological approach Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy Human correlates of provocative questions in pancreatic pathology CIViC database SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.A current perspective on stereotactic body radiation therapy for pancreatic cancer New challenges in perioperative management of pancreatic cancer Advances in chemotherapy for pancreatic cancer Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer.Distal pancreatectomy with celiac axis resection: what are the added risks?Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.

P2860

57a30546df77d4446b86ccf50db68457b5dcf9e4

P248

Q21129230-6D3763A5-9326-457A-84CC-99954C263AED Q24622390-0A5D41D4-280F-4644-BA98-6C729CB4876E Q24626346-9F4235B7-9847-4C1C-B01F-91CC0171AC34 Q26751724-31F9ADFE-3F97-494A-8147-E2DBB2B58C9D Q26765241-14D7E0D1-E023-4D6F-949E-758AEEFBA4E2 Q26765360-17FBD619-62E9-4149-95FA-781304BCC2EA Q26766686-05E2466D-9CF5-4533-8B15-596BFB61DC80 Q26775916-150C0205-692D-4907-9D98-A12B7D632956 Q26781445-7FC9D9B4-A222-4413-BDDE-F6FA1125A2DE Q26781550-3D366945-C174-4359-BACB-D1432BCC4AF1 Q26797248-685A068F-1292-4BBE-8D0A-807F5B64BB22 Q26799428-48E49877-DA85-4856-AAB7-C40D38189A59 Q26799714-F5BF2A45-8B0A-4421-ABD0-71FF90DF034E Q26801834-489E9628-0032-4850-BFCA-37D2C9D66FB5 Q26822703-E85AE458-EAA5-4A3D-AC5A-1B3E52ABD78D Q26824528-09054ADA-E0FB-48EA-8CAD-86E0B06D519D Q26828571-50EA4A19-F8D8-4CE4-8ECD-546BE5B08DEC Q26849671-102B27E8-6A5B-4B34-A4EB-BC56046D2402 Q26859742-2DE24162-DA52-42DA-B5B7-00F013DF2791 Q26991615-37BB9362-465E-4BD2-B3C0-BFBF528EC22D Q27008346-A9CECF6F-D23E-496C-AA3E-D96A3AB715F9 Q27023576-9F0AD34E-D1E9-41DD-957C-99A8B35B3575 Q27612411-F1E45D3B-4130-4902-9329-7DB0F21D6D11 Q27851475-3068EB06-DBBB-4C17-82F9-53C471824BA7 Q28077111-7CC945A4-C164-46CD-9693-40A5419EA432 Q28082422-6536CBBF-0787-409D-8624-FF4B6FDD1603 Q28085711-3873C4BA-95A6-4847-93FD-730479B44FBF Q28552089-4FF6F5CF-80D3-4026-AEDA-0B5D1D57CC4E Q28728326-30D62EC3-4105-428A-AD72-9B1CA23355D6 Q30238706-53E01066-8989-41EB-94B5-3AFE769E2564 Q30249814-01702C2A-FE11-4949-AB7B-3509F0E802AE Q30356819-D9FA528F-6356-41A2-8DD3-32FAC0EBA288 Q30422607-381CCE00-AF0A-4CC5-B854-B7075BE38FA3 Q30423279-61AE2291-ED07-4EA4-8C03-8F88C468F722 Q30528894-D3AAE1D0-B3DD-4F16-8878-0AEF8ED12B40 Q30726275-A0D90836-E448-4E76-B255-CD4B03E03708 Q30754497-999378D9-4973-42F9-A4DE-2C13803A60DC Q30987695-95A20AAD-008D-42AF-8397-7DA3EDB75366 Q31132024-6CA3D1E1-AA46-4931-8152-63F62DE12A61 Q33400984-B8A57992-86E2-444E-A41A-8EE4A037CED8

P2860

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

http://www.wikidata.org/entity/Q27851466

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@ast

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@en

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@nl

type

label

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@ast

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@en

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@nl

altLabel

DPC4 Gene Status of the Primar ...... atients With Pancreatic Cancer

@en

prefLabel

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@ast

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@en

DPC4 gene status of the primar ...... tients with pancreatic cancer.

@nl

P1433

Q27851466-2DBDBE86-90EB-42B7-B83D-58A9A7B9C950

P1476

Q27851466-5D1EBC9D-6BD8-44B2-86F8-4BEB436D2A2F

P2093

Q27851466-34DE1B4F-BF21-438A-9A5D-3C31669DF0D5

Q27851466-41F2F7D6-917E-4848-88A7-6289027280E0

Q27851466-4E519E2B-E862-43CD-BBE3-D7F64B34E351

Q27851466-64B96ECC-1690-4ADB-9EBC-AD26C5F3EA20

Q27851466-74C9B2DC-2BD8-41EC-A13C-092BFE514641

Q27851466-7D586371-32AB-4204-A51E-26D0BB6330FD

Q27851466-931B92FF-B787-4CA0-B182-C4607E087AF5

Q27851466-9C277A49-9FAB-4AB4-BAF3-6419D5407FA3

Q27851466-A189C919-8C4D-4682-9856-8FEF1A39B122

Q27851466-A90218CA-6F2A-4349-B069-348E6ACAD18A

P2860

Q27851466-0596A8E4-45D0-4529-B83F-109DEFEFC72D

Q27851466-15DA16F9-989D-48D7-B8B7-27658514CC6E

Q27851466-16ADA7CE-5D53-4EA4-B8F8-F3FC83EB43EB

Q27851466-1B0C5FCB-A87F-415D-BE14-30A6D7030CC3

Q27851466-21CCDFD9-C397-45C1-8A42-DAB6876360D6

Q27851466-23451595-4723-4F93-B0A1-81D76EE19E8D

Q27851466-2DA374D5-C9F2-43BC-B89D-1BB766621041

Q27851466-2F484D19-52C4-4FEF-BAFC-29D29E285A40

Q27851466-31FF3909-EBE7-4C9C-AA87-E41DBD03B8A7

Q27851466-44B96B58-09BE-4189-BEB8-8DEEFAD47C4B

P304

Q27851466-8C6A6DAA-B19A-4B12-9CF1-1900B99A1390

P31

Q27851466-E6774713-B92D-4F31-A18D-C8135B206E01

P3181

Q27851466-F707B861-93D5-4FFC-BFBB-59012C3C1A3C

P356

Q27851466-0F47134A-031A-4740-9C53-5D61E9ED96D7

P407

Q27851466-5EDF67A9-9087-435D-B490-CD4470FA1485

P433

Q27851466-0E05F87A-6E81-4D08-B458-3A29211FF8D1

P478

Q27851466-EA2486F2-3F45-4F60-94F1-C10652F0E672

P50

Q27851466-16B42D94-D03B-42B8-A3EF-76DB15409D9B

Q27851466-5AAF4B82-7C3B-48E6-816B-EE475167B473

Q27851466-66AA4C19-FC9E-43B4-9BC3-F741E3A0CA84

Q27851466-8E64DFB4-D863-4BE2-A224-0C091BB867FF

Q27851466-BAFF9F60-32EC-410A-9AD0-B63B7E6F9BCB

P577

Q27851466-EE3D3BF9-2F65-47C3-B0DB-DAC5303DAB90

P698

Q27851466-73231159-AD62-408F-98D8-4B155FB348D4

P921

Q27851466-544A3804-3180-4CF0-B61D-9C0567FD17B1

P932

Q27851466-DDB37AD2-BD80-4A32-AB84-78A1B7B6FE1A

P3181

P356

JCO.2008.17.7188

P1433

Journal of Clinical Oncology

P1476

DPC4 gene status of the primar ...... atients with pancreatic cancer

@en

P2093

Alison P Klein

http://www.w3.org/2001/XMLSchema#string

Baojin Fu

http://www.w3.org/2001/XMLSchema#string

Charles J Yeo

http://www.w3.org/2001/XMLSchema#string

Clark M Henderson

http://www.w3.org/2001/XMLSchema#string

Daniel Laheru

http://www.w3.org/2001/XMLSchema#string

Hisashi Abe

http://www.w3.org/2001/XMLSchema#string

James R Eshleman

http://www.w3.org/2001/XMLSchema#string

Jesse W Keller

http://www.w3.org/2001/XMLSchema#string

John L Cameron

http://www.w3.org/2001/XMLSchema#string

Joseph M Herman

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.

Cancer statistics, 2008

Cancer genes and the pathways they control

Identification of pancreatic cancer stem cells

Cancer statistics, 2007

A molecular signature of metastasis in primary solid tumors

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

P304

1806-1813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

541377

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2008.17.7188

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Marc K. Halushka

Felip Vilardell

Christine A Iacobuzio-Donahue

P577

2009-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19273710

http://www.w3.org/2001/XMLSchema#string

P921

P932

2668706

http://www.w3.org/2001/XMLSchema#string